Your browser doesn't support javascript.
loading
Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trial.
Stacchiotti, Silvia; Ferrari, Stefano; Redondo, Andres; Hindi, Nadia; Palmerini, Emanuela; Vaz Salgado, Maria Angeles; Frezza, Anna Maria; Casali, Paolo Giovanni; Gutierrez, Antonio; Lopez-Pousa, Antonio; Grignani, Giovanni; Italiano, Antoine; LeCesne, Axel; Dumont, Sarah; Blay, Jean Yves; Penel, Nicolas; Bernabeu, Daniel; de Alava, Enrique; Karanian, Marie; Morosi, Carlo; Brich, Silvia; Dagrada, Gian Paolo; Vallacchi, Viviana; Castelli, Chiara; Brenca, Monica; Racanelli, Dominga; Maestro, Roberta; Collini, Paola; Cruz, Josefina; Martin-Broto, Javier.
Afiliação
  • Stacchiotti S; Department of Cancer Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Tumori, Milan, Italy. Electronic address: silvia.stacchiotti@istitutotumori.mi.it.
  • Ferrari S; Chemotherapy Unit, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
  • Redondo A; Department of Medical Oncology, University Hospital La Paz, Hospital La Paz Institute for Health Research, Madrid, Spain.
  • Hindi N; Department of Medical Oncology, University Hospital Virgen del Rocio, Seville, Spain; Institute of Biomedicine of Sevilla, Universidad de Sevilla, Seville, Spain.
  • Palmerini E; Chemotherapy Unit, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
  • Vaz Salgado MA; Department of Medical Oncology, University Hospital Ramón y Cajal, Madrid, Spain.
  • Frezza AM; Department of Cancer Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Tumori, Milan, Italy.
  • Casali PG; Department of Cancer Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Tumori, Milan, Italy; Department of Medical Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Gutierrez A; Hematology Department, University Hospital Son Espases, Palma, Illes Baleares, Spain.
  • Lopez-Pousa A; Department of Medical Oncology, Sant Pau Hospital, Barcelona, Spain.
  • Grignani G; Division of Medical Oncology, Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia, IRCCS, Candiolo, Italy.
  • Italiano A; Department of Oncology, Institut Bergonié, Bordeaux, France.
  • LeCesne A; Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France.
  • Dumont S; Department of Medical Oncology, Gustave Roussy Cancer Campus, Villejuif, France.
  • Blay JY; Department of Medical Oncology, Centre Léon Bérard, Lyon, France; Université Claude Bernard Lyon I, Lyon, France.
  • Penel N; Medical Oncology Department, Centre Oscar Lambret, Lille, France.
  • Bernabeu D; Musculoskeletal Imaging Section, University Hospital La Paz, Hospital La Paz Institute for Health Research, Madrid, Spain.
  • de Alava E; Institute of Biomedicine of Sevilla, Universidad de Sevilla, Seville, Spain; Department of Pathology, University Hospital Virgen del Rocio, Seville, Spain.
  • Karanian M; Department of Pathology, Centre Léon Bérard, Lyon, France.
  • Morosi C; Department of Radiology, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Tumori, Milan, Italy.
  • Brich S; Department of Diagnostic Pathology and Laboratory Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Tumori, Milan, Italy.
  • Dagrada GP; Department of Diagnostic Pathology and Laboratory Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Tumori, Milan, Italy.
  • Vallacchi V; Department of Research, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Tumori, Milan, Italy.
  • Castelli C; Department of Research, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Tumori, Milan, Italy.
  • Brenca M; Oncogenetics and Oncogenomics Unit, Centro di Riferimento Oncologico di Aviano IRCCS, Aviano, Italy.
  • Racanelli D; Oncogenetics and Oncogenomics Unit, Centro di Riferimento Oncologico di Aviano IRCCS, Aviano, Italy.
  • Maestro R; Oncogenetics and Oncogenomics Unit, Centro di Riferimento Oncologico di Aviano IRCCS, Aviano, Italy.
  • Collini P; Department of Diagnostic Pathology and Laboratory Medicine, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale Tumori, Milan, Italy.
  • Cruz J; Department of Medical Oncology, University Hospital of Canarias, Tenerife, Spain.
  • Martin-Broto J; Department of Medical Oncology, University Hospital Virgen del Rocio, Seville, Spain; Institute of Biomedicine of Sevilla, Universidad de Sevilla, Seville, Spain.
Lancet Oncol ; 20(9): 1252-1262, 2019 09.
Article em En | MEDLINE | ID: mdl-31331701

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Neoplasias de Tecidos Moles / Sulfonamidas / Protocolos de Quimioterapia Combinada Antineoplásica / Condrossarcoma / Neoplasias de Tecido Conjuntivo e de Tecidos Moles Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Neoplasias de Tecidos Moles / Sulfonamidas / Protocolos de Quimioterapia Combinada Antineoplásica / Condrossarcoma / Neoplasias de Tecido Conjuntivo e de Tecidos Moles Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2019 Tipo de documento: Article País de publicação: Reino Unido